ALX ONCOLOGY HOLDINGS INC Annual Net Cash Provided by (Used in) Financing Activities in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Alx Oncology Holdings Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2023.
  • Alx Oncology Holdings Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $3.09M.
  • Alx Oncology Holdings Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $59.3M, a 501% increase from 2022.
  • Alx Oncology Holdings Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $9.86M, a 299% increase from 2021.
  • Alx Oncology Holdings Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $2.47M, a 99.5% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $59.3M +$49.4M +501% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $9.86M +$7.39M +299% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $2.47M -$460M -99.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-07
2020 $463M +$448M +2914% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
2019 $15.4M +$15.4M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $1K* Jan 1, 2018 Dec 31, 2018 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.